About

Access India Ventures (AIV) is a SEBI-regulated early-stage venture fund focused on India venture capital through disciplined, ownership-driven investing.
We invest at Seed / Seed+ in Indian HealthTech as our core return engine, alongside selective Frontier & Enabling Technologies as capped optionality beyond healthcare.

Our strategy focuses on scalable, evidence-led companies operating in large, inefficient systems where technology can unlock measurable value through workflow improvement, data infrastructure, diagnostics, and software-led operational efficiency.

AIV combines discipline ownership at entry, evidence-based capital allocation, and practical exit pathways.

We prioritise:
• Clear economic buyers
• Early commercial validation
• Repeatable revenue
• Selective capital concentration
• Practical mid-market exit readiness

HealthTech is our primary focus, targeting sectors such as:
• Healthcare workflow automation
• Diagnostics intelligence
• Health data infrastructure
• Insurance and claims infrastructure

Frontier & Enabling Technologies provide selective exposure to software-led platforms beyond healthcare, including:
• Vertical AI / Deeptech
• AI / Data Infrastructure
• AgTech platforms
• Robotics & Automation

Across both sectors, we apply one disciplined investment framework: broad sourcing, selective entry, evidence-gated follow-on, and concentrated conviction.

AIV combines global healthcare and operating experience, India-based execution, and disciplined capital allocation to back scalable companies positioned for repeatable outcomes.

HealthTech-led. Frontier-enabled. Ownership-driven. India-focused.

Past Track Record: Pragmatic, Jiva.ai, Attomarker, 52 North Health, Barinthus Biotherapeutics, Polymateria, Argonaute RNA, IRNovate, Roslin Technologies, 4baseCare, Compass (IPO), Troops.AI (Acquired by Salesforce) , MachinaLabs, Whoop (Exit via Secondaries)

Access India Ventures

Org chart

Teams

Offices